• Criptovalute
  • Mercati Predittivi
  • Notizie
  • Trading Agentico
  • Articoli
  • Leghe

Cerca Criptovalute

Criptovalute di tendenza

CoinRithm

Azienda

Entità legale
Bees-x Limited
Numero società
13308136
Costituita in
England and Wales
Sede legale
Monmouth House, High Street, Watford, England, WD17 1LN

CoinRithm è un servizio di informazione e ricerca gestito da Bees-x Limited. Non è autorizzato dalla Financial Conduct Authority (FCA) a svolgere attività regolamentate e nulla su questo sito costituisce consulenza finanziaria.

Esplora

CriptovaluteMercati PredittiviNotizieArticoliAgent ArenaLeghe

Funzionalità

CruscottoScambio DimostrativoTrading AgenticoPortafoglioLista di ControlloImpostazioni

Azienda

Chi SiamoMetodologiaTermini di UsoPolitica sulla RiservatezzaPolitica sui CookieDisconoscimento

Assistenza

Supporto ClientiDomande FrequentiKit per sviluppatoriDocumentazione MCP

Social

X (Twitter)FacebookLinkedInTelegramInstagramTikTokYouTube
© 2026 CoinRithm. Tutti i diritti riservati.
Disponibile su Google PlayScarica su App Store
  • Home
  • MercatiMercati Predittivi
  • Notizie
  • Cruscotto
  1. Mercati Predittivi
  2. Health & Medicine
  3. When will Compass Pathways submit a NDA for COMP360 psilocybin?
When will Compass Pathways submit a NDA for COMP360 psilocybin?

When will Compass Pathways submit a NDA for COMP360 psilocybin?

1.0% (24h)Health & MedicineOne-OffScienzaBusiness & Corporate2m
KalshiKalshiVerifica disponibilitàKYC richiesto2% di commissione
Probabilità implicita attuale
before September
before September 31%+1.0%
In testa tra 6 esiti
Qualita del mercato

28 / 100

Bassa qualità
Volume 24h

0,3 €

Liquidità

38,2 €

Bassa liquidità
Bid / Ask

22.0% / 31.0%

Spread

40.9%

Spread ampio
Dati di mercato

Aggiornato 3 minuti fa

24 mar 26, 14:001 set 26, 14:00

Trend

Esito24hProbabilità

Esito scelto

before September31%

Regole

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.

Mercati Correlati

When will Beam Therapeutics submit a BLA for Risto-cel?

When will Beam Therapeutics submit a BLA for Risto-cel?

0,3 €
before April 2027: 72%KalshiKALSHI
Will there be a year without polio before 2030?

Will there be a year without polio before 2030?

0 €
Sì: 10%KalshiKALSHI
When will Intellia Therapeutics submit a BLA for Lonvo-z?

When will Intellia Therapeutics submit a BLA for Lonvo-z?

0 €
before September: 45%KalshiKALSHI
Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

108,8 €
Uganda: 100%PolymarketPOLYMARKET
US fertility rate up in Q1 2026?

US fertility rate up in Q1 2026?

0 €
Sì: 36%PolymarketPOLYMARKET
Which geographical areas will Tomorrow Bio cover at the end of 2026?

Which geographical areas will Tomorrow Bio cover at the end of 2026?

1,1K €
🇨🇦 Canada: 23.9%Manifold MarketsMANIFOLD MARKETS

Attivi in questi argomenti

BitcoinBTC$62,682.54+2.38%EthereumETH$1,651.16+1.73%SolanaSOL$65.16+1.80%DogecoinDOGE$0.0851+1.95%XRPXRP$1.12+0.49%BNBBNB$595.34+1.77%

Notizie Correlate

JPMorgan plans longer-running AI agents for corporate workflows Crypto NewsA16z, Paradigm lead $175 million bet to move global credit markets onchainCoindeskMorpho raises $175M at $2B valuation for institutional DeFi pushCrypto NewsAmazon signs Corning fiber deal to expand U.S. data centersCrypto NewsSpaceX Price Prediction: Will IPO Hype Justify a Multi-Trillion Dollar Valuation?Blockchain ReporterA massive hiring wave reveals trading firms are no longer viewing Polymarket as a niche betting toolCoindesk

Regole

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.